LG Life Sciences Begins Phase III Trials for Humira Biosimilar

Published date13 June 2016
Law FirmGoodwin
Subject MatterBiosimilars,Clinical Trials,Japan,License Agreements,Pharmaceutical Industry,Prescription Drugs,South Korea

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT